← FDA Drug Approvals (Drugs@FDA)

ALTRENO

NDA · New Drug Application · Sponsor: DOW PHARM · Approved 2018-08-23

Drug application

FDA Application #

NDA209353

Application type

New Drug Application

Brand name

ALTRENO

Generic name

TRETINOIN

Active ingredients

TRETINOIN

Dosage form

LOTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

DOW PHARM

Manufacturer

Bausch Health US, LLC

First approval

2018-08-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown